NCT02910167View on ClinicalTrials.gov

Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima

CompletedOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

October 15, 2016

Primary Completion Date

February 20, 2017

Study Completion Date

February 20, 2017

Conditions
Acute PainDysmenorrhea
Interventions
DRUG

Hyoscine n-butylbromide

Hyoscine n-butylbromide 10 mg

DRUG

Paracetamol

Paracetamol 500 mg

DRUG

Hyoscine n-butylbromide

Hyoscine n-butylbromide 10 mg

DRUG

Paracetamol

Paracetamol 500 mg

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY